期刊文献+

荧光原位杂交检测多发性骨髓瘤患者△13及其临床意义 被引量:10

Chromosome 13q deletion detected by interphose FISH in multiple myeloma: a study of 100 cases in China
原文传递
导出
摘要 目的总结100例多发性骨髓瘤(MM)患者荧光原位杂交(FISH)检测△13(13q-/-13)阳性率及其临床意义。方法对100例MM患者采用RB-1探针行FISH检测,并结合常规染色体(CC)结果分析其临床意义。结果(1)△13FISH检出率为19.0%,CC检出率为10.0%,差异未达统计学显著性(P=0.053)。(2)单因素分析示FISH检测△13阳性率〉50%、CC检测克隆性△13(C13A)、非超二倍体核型、FISH检测和CC检测双阳性、血β2-MG≥3.5mg/L为不良预后因素。(3)多因素分析示FISH检测A13阳性率〉50%和血β2-MG≥3.5mg/L是独立预后因素。(4)根据上述两个独立预后因素,可将患者分为低、中、高危3组,两两比较总体生存时间(OS),差异均有统计学意义。结论(1)FISH检测提高了初治MM遗传学异常的检出率。(2)预后分析示FISH检测△13阳性率〉50%和血β2-MG水平为独立预后因素。 Objective To summarize the clinical significance and 13q- characters of 100 multiple myeloma (MM) patients detected by interphase fluorescence in situ hybridization (i-FISH). Methods Specimens of bone marrow were collected from 100 patients with MM who visited the Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences in Tianjin, China. Chromosome Rbanding analysis and i-FISH were conducted. Results (1)i-FISH was used to investigate 100 patients with MM , whose median age was 56 years and 19 (19.0%) cases showed chromosome 13q deletions/ monosony13 ( △13 ) ; conventional cytogenetics (CC) revealed informative MM karyotypes in 24 patients (24. 0% ) ,with △13 in 10(10. 0% ) of them. Detection rate of the two methods had no significant difference (P = 0. 053 ), but in newly diagnosed patients i-FISH was much more sensitive than CC test (Detection rate,25. 3% vs 9. 3% , P = 0. 008 ). ( 2 ) Among the whole cases, 93 of them had complete follow-up information. The overall survival (OS) of the 93 patients was 41 ( 1 - 69) months. Univariate analysis showed that the positive rate of △13 detected by i-FISH 〉 50%, clonal chromosome 13 abnormality (C13A), nonhyperdiploidy, △13 detected by both CC and i-FISH, β2-MG≥3.5 mg/L were associated with significantly shorter OS. Multivariate analysis indicated that the positive rate of △13 detected by i-FISH 〉 50% and β2-MG /〉 3.5 mg/L were the independent unfavorable factors. (3) According to the two independent unfavorable factors mentioned above, we divided the 93 patients into three groups: low-risk, standard-risk and high-risk. And there were significant differences of OS among the 3 groups (P 〈 0. 05 ). Conclusion (1)FISH studies demonstrate a high sensitivity at detecting chromosome 13 abnormality and should be used in the routine evaluation of MM. (2) the positive rate of △13 detected by i-FISH 〉50% and 132-MG≥3.5 mg/L were the independent adverse prognostic factors.
出处 《中华医学杂志》 CAS CSCD 北大核心 2009年第28期1979-1982,共4页 National Medical Journal of China
关键词 发性骨髓瘤 13号染色体 荧光原位杂交 Multiple myeloma Chromosome 13 Fluoresecence in situ hybridization
  • 相关文献

参考文献13

  • 1International Myeloma Working Group.Criteria for the classification of monoclonal gammopathies,multiple myeloma and related disorders:a report of the International Myeloma Working Group.Br J Haematol,2003,121:749-757.
  • 2San Miguel JF,Gareia-Sanz R.Prognostic features of multiple myeioma.Best Pract Res Clin Haematol,2005,18:569-583.
  • 3Facon T,Aver-Loiseau H,Guillerm G,et al.Chromosome 13 abnormalities identified by FISH analysis and serum beta2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy.Blood,2001,97:1566-1571.
  • 4张艳,江滨,黄晓军,师岩,何琦,党辉,邱镜滢,陆道培.多发性骨髓瘤的细胞遗传学研究[J].中国实验血液学杂志,2007,15(1):76-78. 被引量:20
  • 5Fiserova A,Hajek R,Holubova V,et al.Detection of 13q abnormalities in multiple myeloma using immunomagnetically selected plasma cells.Neoplasma,2002,49:300-306.
  • 6刘淑艳,李建勇,陈丽娟,黄金文,潘金兰,仇海荣,沈云峰,徐卫,薛永权.多发性骨髓瘤分子细胞遗传学异常的研究[J].中华血液学杂志,2007,28(4):223-226. 被引量:8
  • 7Fonseca R,Harrington D,Oken MM,et al.Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13)in multiple myeloma:an eastern cooperative oncology group study.Cancer Res,2002,62:715-720.
  • 8邓书会,徐燕,王亚非,麦玉洁,刘旭平,赵耀中,邹德慧,王迎,邱录贵.100例多发性骨髓瘤患者细胞遗传学分析[J].中华医学杂志,2007,87(24):1685-1688. 被引量:2
  • 9Zojer N,Konigsberg R,Ackermann J,et al.In multiple myeloma,deletion of 13q14 remains an independent adverse prognostic parameter despite its frequent detection by interphase FISH.Blood,2000,95:1925-1930.
  • 10Kaufmann H,Kromer E,Nesslinger T,et al.Both chromosome 13 abnormalities by metaphase cytogenetics and deletion of 13q by interphase FISH only are prognostically relevant in multiple myeloma.Eur J Haematol,2003,71:179-183.

二级参考文献26

  • 1刘淑艳,薛永权,黄金文.荧光原位杂交技术在多发性骨髓瘤染色体异常检测中的应用[J].国外医学(输血及血液学分册),2005,28(5):432-435. 被引量:3
  • 2Debes-Marum CS, Dewald GW, Bryant S, et al. Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma. Leukemia, 2003 ; 17:427 - 436
  • 3Lai JL, Zandecki M, Mary JY, et al. Improved cytogenetics in multiple myeloma:a study of 151 patients including 117 patients at diagnosis. Blood, 1995 ; 85:2490 - 2497
  • 4Harrison C J, Mazzullo H, Cheung KL, et al. Cytogenetics of multiple myeloma:interpretation of fluorescence in situ hybridization resuits. Br J Haematol, 2003; 120:944 -952
  • 5Avet-Loiseau H, Facon T, Grosbois B, et al. Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation. Blood, 2002; 99:2185-2191
  • 6Zojer N, Konigskerg R, Ackermann J, etal. Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization. Blood, 2000; 95: 1925- 1930
  • 7Pantou D, Rizou H, Tsarouha H, et al. Cytogenetic manifestations of multiple myeloma heterogeneity. Genes-Chromosomes-Cancer,2005 ; 42 : 44 - 57
  • 8Fiserova A, Hajek R, Holubova V, et al. Detection of 13 q abnormalities in multiple myeloma using immunomagnetically selected plasma cells. Neoplasma, 2002,49:300-306.
  • 9Greipp PR, San Miguel J, Dude BG, et al. International staging system for multiple myeloma. J Clin Oncol, 2005, 23:3412-3420.
  • 10Smadja NV, Fruchart C, Isnard F, et al. Chromosomal analysis in multiple myeloma: cytogenetic evidence of two different diseases.Leukemia, 1998, 12:960-969.

共引文献27

同被引文献100

  • 1王惠平.多发性骨髓瘤患者血清β_2-微球蛋白的测定及临床意义[J].医学临床研究,2004,21(9):1068-1069. 被引量:3
  • 2郑元,仇惠英,许丽萍,丰斌,潘金兰,薛永权.荧光原位杂交检测多发性骨髓瘤18号染色体异常[J].临床检验杂志,2006,24(3):215-215. 被引量:5
  • 3刘淑艳,李建勇,陈丽娟,黄金文,潘金兰,仇海荣,沈云峰,徐卫,薛永权.多发性骨髓瘤分子细胞遗传学异常的研究[J].中华血液学杂志,2007,28(4):223-226. 被引量:8
  • 4Bouafia F,Drai J,Bienvenu J,et al.Profiles and prognostic values of serum LDH isoenzymes in patients with haemtopoietic malignancies.Bull Cancer,2004,91(7-8):229-240.
  • 5Colovi M,Jankovi G,Suvajdzi N,et al.Thirty patients with primary plasma cell leukemia:a single center experience.Med Oncol,2008,25(2):154-160.
  • 6Perez-Andres M,Atmeida J,Martin-Ayuso M,et al.Soluble and membrane levels of molecules involved in the interaction between clonal plasma cells and the immunological microenvironment in multiple myeloma and their association with the characteristics of the disease.Int J Cancer,2009,124(2):367-375.
  • 7Lauta VM.A review of the cytokine network in multiple myeloma:diagnostic,prognostic,and therapeutic implications.Cancer,2003,97:2440-2452.
  • 8Aiexandrakis MC,Passam FH,Ganotakis ES,et al.The clinical and prognostic significance of erythrocyte sedimentaition rate (ESR),serum interleukin-6(IL-6)and acute phase protein levels in multiple myelomag.Ciln Lab Haematol,2003,25(1):41-46.
  • 9Weiss BM,Abadie J,Verma P,et al A monoclonal gammopathy precedes multiple myeloma in most patients.Blood,2009,113:5418-5422.
  • 10Kyle RA,Kumar S.The significance of monoclonal gammopathy of undetermined significance.Haematologica,2009,94:1641-1644.

引证文献10

二级引证文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部